Agenda and minutes

Venue: Committee Room 1 - Senedd. View directions

Contact: Claire Morris 

Media

Senedd.TV: View the webcast

Items
Expected timing No. Item

10.

Transcript

View the meeting transcript (PDF 656KB) View as HTML (403KB)

1.

Introductions, apologies, substitutions and declarations of interest

Minutes:

1.1 The Chair welcomed Members to the meeting.

1.2 Apologies were received from Angela Burns AM.

(09.30 - 10.15)

2.

Use of antipsychotic medication in care homes - evidence session 4 - Public Health Wales NHS Trust

Michaela Morris, Mental Health Service Improvement Manager, Public Health Wales.

Rhiannon Davies

 

Supporting documents:

Minutes:

2.1 The Committee received evidence from representatives of Public Health Wales NHS Trust.

(10.20 - 11.05)

3.

Use of antipsychotic medication in care homes - evidence session 5 - Royal College of Psychiatrists and Royal College of General Practitioners

Dr Victor Aziz, Royal College of Psychiatrists

Dr Jane Fenton-May, Royal College of General Practitioners

Supporting documents:

Minutes:

3.1 The Committee received evidence from representatives of the Royal College of Psychiatrists and the Royal College of General Practitioners.

(11.15 - 11.45)

4.

Use of antipsychotic medication in care homes - evidence session 6 - Royal College of Nursing

Alison Davies, Associate Director Professional Practice, Royal College of Nursing Wales

Helen Bennett, Mental Health Nurse and Mental Health Consultant, Royal College of Nursing Wales

Supporting documents:

Minutes:

4.1 The Committee received evidence from representatives of the Royal College of Nursing.

(11.50 - 12.35)

5.

Use of antipsychotic medication in care homes - evidence session 7 - Royal Pharmaceutical Society and Community Pharmacy Wales

Mair Davies, Director, Royal Pharmaceutical Society Wales

Wendy Davies, Mental Health Clinical Board Pharmacist, Royal Pharmaceutical Society Wales

Steve Simmonds, Community Pharmacy Wales

Sam Fisher, Community Pharmacy Wales

Supporting documents:

Minutes:

5.1 The Committee received evidence from representatives of the Royal Pharmaceutical Society and Community Pharmacy Wales.

5.2 The Royal Pharmaceutical Society and Community Pharmacy Wales agreed to provide additional evidence.

(13.15 - 13.45)

6.

Use of antipsychotic medication in care homes - evidence session 8 - British Psychological Society

Dr Ian James, British Psychological Society

Dr Carolien Lamers, British Psychological Society

Supporting documents:

Minutes:

6.1 The Committee received evidence from representatives of the British Psychological Society.

7.

Paper(s) to note

7.1

Inquiry into the use of antipsychotic medication in care homes - note of session on 21 September 2017

Supporting documents:

Minutes:

7.1a The Committee noted the note of the private session on 21 September 2017.

8.

Motion under Standing Order 17.42 to resolve to exclude the public from the remainder of the meeting

Minutes:

8.1 The Committee agreed the motion.

(13.45 - 14.00)

9.

Use of antipsychotic medication in care homes - consideration of evidence

Minutes:

9.1 The Committee considered the evidence given during items 2, 3, 4, 5 and 6 of the meeting.

(14.00 - 15.00)

10.

Inquiry into loneliness and isolation - consideration of draft report

Supporting documents:

Minutes:

10.1 The Committee agreed to defer the consideration of the draft report until it’s meeting on 11 October 2017.